Vernalis Share Discussion Threads

[jasonavfc19] 15/5/2018 11:09

Cash £46m No Debts
9 products in development and 3 approved
Multiple Partnerships
Whats not to like!

[joeblogg2] 15/5/2018 11:04

timbo reckons this is worth more than current mkt cap especially with so much tax losses, another company could reverse here???

[cottoner] 15/5/2018 10:55

twitter promotion :-)

[joeblogg2] 15/5/2018 10:54

what's happening??

[meijiman] 09/5/2018 09:50

Some useful posts on the Verona board which might have some relevance to Vernalis.

[romeike] 02/5/2018 14:08

This board has spent over two years keeping shareholders (and analysts) in the dark on everything, what makes you think they would change their tune now? The CEO is quite simply way out of his depth. It is not clear that anyone has any interest in buying Vernalis, it is more likely that the company will be left struggling to survive under a new CEO.

[chrisdgb] 29/4/2018 07:57

Would be nice to get an update on the sale process and give holders a steer of the value...?

[romeike] 26/4/2018 11:10

How much further evidence of the incompetence of Ian Garland is needed following the total waste of millions upon millions of pounds to create the wet fart that is the now defunct Vernalis US business? A total embarrassment to UK business.

Literally every decision they took was bad and they ceased meaningful communication with investors at a very early stage opting to bunker down and stubbornly insist on their failing strategy that has cost so much and produced less than nothing.

[waterloo01] 25/4/2018 17:51

They are essentially up for sale so that process will either unlock value or not. So not sure why a research note at this point is of use to anyone.

O/T Hi Timbo. Saw you at a distance at UKIS. We met at IMM AGM. Hope that worked out for you. Cheers

[meijiman] 25/4/2018 17:48

Yes 16p discounted for the time value of money sounds right. Trouble is the ceo is a
dead weight on perception....time for the company to commission a research note setting out the potential locked in value here.

[timbo003] 25/4/2018 16:59

The rise should come as no surprise to anyone. Even after the restructuring, there is a reasonable chance that there will be up to 6p/share (£30m) on the balance sheet and the remaining business should be worth at least 10p/share based on a risk adjusted future cash flow.

[romeike] 29/3/2018 10:19

Garland still very much in charge or he'd have left the building already. Stock is toxic while he is still at the helm. Needs an established turn-around specialist and fast.

[romeike] 29/3/2018 07:58

A total failure all round and yet the sheer arrogance to press ahead with the distribution of free shares to executives. Rewards for failure.

Why have they not announced clawback of massive bonus payments made to disgraceful CEO, Ian Garland?

[timbo003] 29/3/2018 05:51

Surely it will be Woodford and Invesco calling all the shots now rather than the failed management.

Looking at two other situations where Woodford has ended up with an Aim quoted duffer (OXP and SPHR), I think it is unlikely that there will be an outright sale of the company.

Maybe they will go down the same route as Oxford PharmaScience (OXP) which last summer was a failed Pharm Tech company (market cap circa £16m) which had spent a fortune trying to develop a technology which had run into big regulatory problems, it also owned a small profitable pharmaceutical taste mask business and had a large remaining cash pile (£20m+).

OXP has now split into two, with the cash pile remaining as a quoted shell looking out for suitable Reverse takeover targets, the rest of the business has separated and is now an unquoted company which will assess its options on whether to continue trying to develop the main technology, or to go back to their roots and focus on the taste masking side of the business.

[catch007] 28/3/2018 16:21

Its simply a question of damage control now to see if any value can be gained by a stricken company holding cash & assets or just take the wipe out value on the share price and sell at huge loss. Hardly a great choice! An incompetent board of Directors have ruined the company.

[romeike] 28/3/2018 15:23

They doubled sales by halving the price of the product, sheer brilliance from this management team. I hope the hopeless Ian Garland will be refunding the company his last three years obscene salary and bonuses.

[waterloo01] 28/3/2018 07:58

Indeed plus the £45m in cash/equivalent at end Feb.

[timbo003] 28/3/2018 07:53

I am more than happy with that announcement, points of interest (for me) are as follows:

* All US intangibles now totally written off which seems fair, so if they manage to get anything at all for Tuzistra, that would be an unexpected bonus.

* They state that they have adequate financial resources to continue in operation for the foreseeable future.

* The income from Frova continues until April 2019

* They highlight the recent progress that Verona Pharma have made with RPL554, although I am not sure why the Vernalis BOD do not disclose any of the details regarding the financial stake they have for RPL554, as all the information is out there in the public domain for anyone who cares to look in the right place (see Verona Pharma Aim Admission document)

[romeike] 27/3/2018 21:50

Looks to me like a lot of the sales reps were on their first contract. I think we haven't yet heard everything there is to come out about this fiasco. Fair value may well be 16p but that won't stop this going to a penny in the short term.

[timbo003] 27/3/2018 16:06

Tomorrow's results will no doubt be awful and the accompanying statement will have been largely written by 2 directors who have been given their marching orders. But I wonder how much of the disaster story we will read about tomorrow is already priced in?